T2 Biosystms Stock Market Value
| TTOO Stock | USD 0.49 0.02 3.92% |
| Symbol | TTOO |
T2 Biosystms Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share 0.999 | Quarterly Revenue Growth (0.01) | Return On Assets (0.90) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
T2 Biosystms 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to T2 Biosystms' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of T2 Biosystms.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in T2 Biosystms on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding T2 Biosystms or generate 0.0% return on investment in T2 Biosystms over 30 days. T2 Biosystms is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United ... More
T2 Biosystms Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure T2 Biosystms' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess T2 Biosystms upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.48) | |||
| Maximum Drawdown | 26.0 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 5.98 |
T2 Biosystms Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for T2 Biosystms' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as T2 Biosystms' standard deviation. In reality, there are many statistical measures that can use T2 Biosystms historical prices to predict the future T2 Biosystms' volatility.| Risk Adjusted Performance | (0.34) | |||
| Jensen Alpha | (2.87) | |||
| Total Risk Alpha | (3.70) | |||
| Treynor Ratio | (3.23) |
T2 Biosystms Backtested Returns
T2 Biosystms retains Efficiency (Sharpe Ratio) of -0.47, which indicates the company had a -0.47% return per unit of price deviation over the last 3 months. T2 Biosystms exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate T2 Biosystms' market risk adjusted performance of (3.22), and Information Ratio of (0.48) to confirm the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 0.86, which indicates possible diversification benefits within a given portfolio. T2 Biosystms returns are very sensitive to returns on the market. As the market goes up or down, T2 Biosystms is expected to follow. At this point, T2 Biosystms has a negative expected return of -2.79%. Please make sure to validate T2 Biosystms' jensen alpha, as well as the relationship between the kurtosis and price action indicator , to decide if T2 Biosystms performance from the past will be repeated sooner or later.
Auto-correlation | 0.69 |
Good predictability
T2 Biosystms has good predictability. Overlapping area represents the amount of predictability between T2 Biosystms time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of T2 Biosystms price movement. The serial correlation of 0.69 indicates that around 69.0% of current T2 Biosystms price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.69 | |
| Spearman Rank Test | 0.78 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
T2 Biosystms lagged returns against current returns
Autocorrelation, which is T2 Biosystms stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting T2 Biosystms' stock expected returns. We can calculate the autocorrelation of T2 Biosystms returns to help us make a trade decision. For example, suppose you find that T2 Biosystms has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
T2 Biosystms regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If T2 Biosystms stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if T2 Biosystms stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in T2 Biosystms stock over time.
Current vs Lagged Prices |
| Timeline |
T2 Biosystms Lagged Returns
When evaluating T2 Biosystms' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of T2 Biosystms stock have on its future price. T2 Biosystms autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, T2 Biosystms autocorrelation shows the relationship between T2 Biosystms stock current value and its past values and can show if there is a momentum factor associated with investing in T2 Biosystms.
Regressed Prices |
| Timeline |
Pair Trading with T2 Biosystms
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if T2 Biosystms position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in T2 Biosystms will appreciate offsetting losses from the drop in the long position's value.Moving together with TTOO Stock
| 0.77 | ME | 23Andme Holding | PairCorr |
| 0.92 | VALN | Valneva SE ADR | PairCorr |
| 0.77 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against TTOO Stock
| 0.61 | KZR | Kezar Life Sciences | PairCorr |
| 0.52 | MLYS | Mineralys Therapeutics, | PairCorr |
| 0.5 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.38 | NXGLW | NexGel Warrant | PairCorr |
| 0.37 | RNXT | RenovoRx | PairCorr |
The ability to find closely correlated positions to T2 Biosystms could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace T2 Biosystms when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back T2 Biosystms - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling T2 Biosystms to buy it.
The correlation of T2 Biosystms is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as T2 Biosystms moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if T2 Biosystms moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for T2 Biosystms can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out T2 Biosystms Correlation, T2 Biosystms Volatility and T2 Biosystms Alpha and Beta module to complement your research on T2 Biosystms. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
T2 Biosystms technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.